PSNL
Neutral signal
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Pulls against a bullish reading. Selling cluster — sale value, no purchase value
- Congress Unavailable or mixed. 1 purchase disclosure year to date, a thin reading
- Financial indicators Unavailable or mixed. Current ratio 6.76 · operating margin -126% — readings disagree
- Narrative Pulls against a bullish reading. Stored narrative reading is in the bearish band
- Timing Supports a bullish reading. Interesting trend — weekly bias up
VENTE TOTALE: 7 459 titres (~120 984,98 $ US)
- Insiders
- Hall Christopher M
- Total bought
-
—
Avg buy (VWAP, 90d window) —
- Total sold
-
$120,985
Avg sell (VWAP, 90d window) $15.17 vs last close $16.46 (+8.5%)
- Last activity
- 2026-09-18
- Liquidity
- Liquid $39,463,409/day · 20d vol
- Last synced
-
2026-09-25 21:10:49
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-09-18 | Chen Richard | Sell | 3,998 | $16.22 | $64,848 | Form 4 |
| 2026-09-18 | Hall Christopher M | Sell | 7,459 | $16.22 | $120,985 | Form 4 |
| 2026-09-18 | Moore Stephen Michael | Sell | 2,068 | $16.22 | $33,543 | Form 4 |
| 2026-09-18 | Tachibana Aaron | Sell | 2,931 | $16.22 | $47,541 | Form 4 |
| 2026-07-15 | Chen Richard | Sell | 100,000 | $15.15 | $1,515,000 | Form 4 |
| 2026-07-09 | Hall Christopher M | Sell | 100,000 | $15.08 | $1,508,000 | Form 4 |
| 2026-06-29 | Tachibana Aaron | Sell | 4,982 | $14.00 | $69,748 | Form 4 |
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
Market snapshot
Signal
Neutral signalScored 2026-09-23
PSNL presents a deeply unfavorable profile combining severe fundamental deterioration (score: 25) with a complete absence of bullish catalysts (score: 0), resulting in a near-floor composite score.
The first sentence of the analysis written for PSNL on 2026-09-23 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 22.7% | 31.7% | 24.8% | 20.5% | 37.0% | |
| Ebit Margin | -116.4% | -96.0% | -147.1% | -173.8% | -76.1% | |
| Ebitda Margin | -101.9% | -83.1% | -131.7% | -160.9% | -69.0% | |
| Operating Profit Margin | -126.4% | -80.7% | -131.0% | -177.6% | -76.4% | |
| Pretax Profit Margin | -116.7% | -96.0% | -147.3% | -174.1% | -76.3% | |
| Continuous Operations Profit Margin | -116.7% | -96.1% | -147.4% | -174.2% | -76.3% | |
| Net Profit Margin | -116.7% | -96.1% | -147.4% | -174.2% | -76.3% | |
| Bottom Line Profit Margin | -116.7% | -96.1% | -147.4% | -174.2% | -76.3% | |
| Current Ratio | 6.761 | 6.522 | 3.107 | 6.028 | 10.163 | |
| Quick Ratio | 6.606 | 6.395 | 2.987 | 5.835 | 10.033 | |
| Solvency Ratio | -0.976 | -1.045 | -1.014 | -1.407 | -0.687 | |
| Cash Ratio | 3.135 | 2.937 | 1.206 | 2.690 | 3.372 | |
| Price To Earnings Ratio | -8.747 | -4.219 | -0.933 | -0.798 | -9.577 | |
| Price To Earnings Growth Ratio | 0.261 | 0.108 | 0.101 | -0.012 | -0.396 | |
| Forward Price To Earnings Growth Ratio | 0.261 | 0.108 | 0.101 | -0.012 | -0.396 | |
| Price To Earnings Diluted Ratio | -8.747 | -4.219 | -0.933 | -0.798 | -9.577 | |
| Price To Earnings Diluted Growth Ratio | 0.261 | 0.108 | 0.101 | -0.012 | -0.396 | |
| Price To Book Ratio | 2.720 | 1.687 | 0.782 | 0.415 | 2.018 | |
| Price To Sales Ratio | 10.199 | 4.047 | 1.377 | 1.391 | 7.325 | |
| Price To Free Cash Flow Ratio | -8.941 | -7.325 | -1.506 | -0.753 | -7.646 | |
| Price To Operating Cash Flow Ratio | -9.478 | -7.585 | -1.798 | -1.289 | -8.842 | |
| Debt To Assets Ratio | 0.120 | 0.164 | 0.212 | 0.166 | 0.147 | |
| Debt To Equity Ratio | 0.153 | 0.218 | 0.369 | 0.223 | 0.188 | |
| Debt To Capital Ratio | 0.133 | 0.179 | 0.269 | 0.182 | 0.158 | |
| Long Term Debt To Capital Ratio | 0.109 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Financial Leverage Ratio | 1.279 | 1.332 | 1.739 | 1.342 | 1.278 | |
| Working Capital Turnover Ratio | 0.348 | 0.624 | 0.552 | 0.287 | 0.366 | |
| Operating Cash Flow Ratio | -1.891 | -1.451 | -1.191 | -2.120 | -2.262 | |
| Operating Cash Flow Sales Ratio | -1.076 | -0.534 | -0.766 | -1.080 | -0.828 | |
| Free Cash Flow Operating Cash Flow Ratio | 1.060 | 1.036 | 1.194 | 1.710 | 1.156 | |
| Debt Service Coverage Ratio | -50.910 | -41.535 | -55.177 | -43.275 | -29.662 | |
| Interest Coverage Ratio | -429.546 | -2,844.458 | -875.400 | -574.781 | -355.179 | |
| Short Term Operating Cash Flow Coverage Ratio | -62.980 | -27.052 | -34.179 | -31.665 | -39.218 | |
| Operating Cash Flow Coverage Ratio | -1.876 | -1.020 | -1.179 | -1.444 | -1.214 | |
| Capital Expenditure Coverage Ratio | -16.640 | -28.166 | -5.156 | -1.408 | -6.391 | |
| Dividend Paid And Capex Coverage Ratio | -16.640 | -28.166 | -5.156 | -1.408 | -6.391 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | -8.818 | -4.201 | -0.949 | -0.478 | -9.811 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 22.7% | ▼-9.0% | ▼-4.7% |
| Ebit Margin | -116.4% | ▼-20.3% | ▲5.5% |
| Ebitda Margin | -101.9% | ▼-18.9% | ▲7.4% |
| Operating Profit Margin | -126.4% | ▼-45.8% | ▼-8.0% |
| Pretax Profit Margin | -116.7% | ▼-20.6% | ▲5.4% |
| Continuous Operations Profit Margin | -116.7% | ▼-20.6% | ▲5.4% |
| Net Profit Margin | -116.7% | ▼-20.6% | ▲5.4% |
| Bottom Line Profit Margin | -116.7% | ▼-20.6% | ▲5.4% |
| Current Ratio | 6.761 | ▲0.239 | ▲0.245 |
| Quick Ratio | 6.606 | ▲0.212 | ▲0.235 |
| Solvency Ratio | -0.976 | ▲0.069 | ▲0.050 |
| Cash Ratio | 3.135 | ▲0.198 | ▲0.467 |
| Price To Earnings Ratio | -8.747 | ▼-4.528 | ▼-3.892 |
| Price To Earnings Growth Ratio | 0.261 | ▲0.153 | ▲0.248 |
| Forward Price To Earnings Growth Ratio | 0.261 | ▲0.153 | ▲0.248 |
| Price To Earnings Diluted Ratio | -8.747 | ▼-4.528 | ▼-3.892 |
| Price To Earnings Diluted Growth Ratio | 0.261 | ▲0.153 | ▲0.248 |
| Price To Book Ratio | 2.720 | ▲1.032 | ▲1.195 |
| Price To Sales Ratio | 10.199 | ▲6.152 | ▲5.331 |
| Price To Free Cash Flow Ratio | -8.941 | ▼-1.616 | ▼-3.707 |
| Price To Operating Cash Flow Ratio | -9.478 | ▼-1.893 | ▼-3.680 |
| Debt To Assets Ratio | 0.119 | ▼-0.044 | ▼-0.042 |
| Debt To Equity Ratio | 0.153 | ▼-0.065 | ▼-0.077 |
| Debt To Capital Ratio | 0.133 | ▼-0.046 | ▼-0.052 |
| Long Term Debt To Capital Ratio | 0.109 | ▲0.109 | ▲0.087 |
| Financial Leverage Ratio | 1.279 | ▼-0.052 | ▼-0.115 |
| Working Capital Turnover Ratio | 0.348 | ▼-0.276 | ▼-0.087 |
| Operating Cash Flow Ratio | -1.891 | ▼-0.441 | ▼-0.108 |
| Operating Cash Flow Sales Ratio | -1.076 | ▼-0.542 | ▼-0.219 |
| Free Cash Flow Operating Cash Flow Ratio | 1.060 | ▲0.025 | ▼-0.171 |
| Debt Service Coverage Ratio | -50.910 | ▼-9.374 | ▼-6.798 |
| Interest Coverage Ratio | -429.546 | ▲2414.912 | ▲586.327 |
| Short Term Operating Cash Flow Coverage Ratio | -62.980 | ▼-35.928 | ▼-23.961 |
| Operating Cash Flow Coverage Ratio | -1.876 | ▼-0.856 | ▼-0.529 |
| Capital Expenditure Coverage Ratio | -16.640 | ▲11.526 | ▼-5.088 |
| Dividend Paid And Capex Coverage Ratio | -16.640 | ▲11.526 | ▼-5.088 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | -8.818 | ▼-4.617 | ▼-3.966 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $710.4M | $342.5M | $101.2M | $90.5M | $626.3M | |
| Enterprise value | $626.1M | $295.3M | $91.9M | $50.0M | $579.0M | |
| EV / Sales | 8.99x | 3.49x | 1.25x | 0.77x | 6.77x | |
| EV / Op. cash flow | -8.35x | -6.54x | -1.63x | -0.71x | -8.18x | |
| EV / Free cash flow | -7.88x | -6.32x | -1.37x | -0.42x | -7.07x | |
| EV / EBITDA | -8.82x | -4.20x | -0.95x | -0.48x | -9.81x | |
| Net debt / EBITDA | 1.19x | 0.67x | 0.10x | 0.39x | 0.80x | |
| Current ratio | 6.76x | 6.52x | 3.11x | 6.03x | 10.16x | |
| Income quality | 0.92x | 0.56x | 0.52x | 0.62x | 1.09x | |
| Graham net-net | $2 | $2 | $1 | $2 | $5 | |
| Tax burden | 100.0% | 100.0% | 100.1% | 100.0% | 100.0% | |
| Interest burden | 100.3% | 100.0% | 100.1% | 100.2% | 100.3% | |
| Working capital | $228.3M | $171.9M | $99.5M | $166.6M | $286.9M | |
| Invested capital | $288.3M | $236.6M | $174.7M | $255.0M | $360.4M | |
| Return on assets | -24.3% | -30.1% | -48.1% | -38.7% | -16.4% | |
| Operating ROA | -29.1% | -27.6% | -37.2% | -33.5% | -20.4% | |
| Return on tangible assets | -24.3% | -30.1% | -48.1% | -38.7% | -16.4% | |
| Return on equity | -31.1% | -40.0% | -83.7% | -51.9% | -21.0% | |
| Return on invested capital | -29.1% | -27.5% | -51.4% | -43.2% | -17.6% | |
| Return on capital employed | -29.9% | -28.5% | -54.1% | -44.5% | -17.9% | |
| Earnings yield | -11.4% | -23.7% | -107.0% | -125.2% | -10.4% | |
| Free cash flow yield | -11.2% | -13.7% | -66.4% | -132.7% | -13.1% | |
| Capex / Op. cash flow | -6.0% | -3.6% | -19.4% | -71.0% | -15.6% | |
| Capex / Depreciation | 44.8% | 14.7% | 96.6% | 591.7% | 184.3% | |
| Capex / Sales | 6.5% | 1.9% | 14.8% | 76.7% | 13.0% | |
| SG&A / Sales | 76.9% | 54.6% | 67.7% | 98.3% | 55.8% | |
| R&D / Sales | 72.2% | 57.8% | 88.2% | 99.8% | 57.7% | |
| Stock comp / Sales | 13.5% | 12.6% | 19.1% | 29.9% | 16.8% | |
| Intangibles / Total assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Days sales outstanding | 85d | 35d | 88d | 93d | 79d | |
| Days payables outstanding | 88d | 40d | 99d | 91d | 63d | |
| Operating cycle | 127d | 60d | 125d | 138d | 107d | |
| Cash conversion cycle | 39d | 20d | 27d | 48d | 44d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▲+107.4%EV / Sales ▲+157.6%EV / EBITDA ▼-109.9%EV / Op. cash flow ▼-1.813Earnings yield ▲+0.123
Profitability
Return on equity ▲+0.089Return on assets ▲+0.058Return on invested capital ▼-0.016Return on capital employed ▼-0.014Operating ROA ▼-0.016Income quality ▲+0.367Tax burden +0.000
Efficiency
Days sales outstanding ▲+49.800Days payables outstanding ▲+47.602Operating cycle ▲+66.316Cash conversion cycle ▲+18.714Capex / Sales ▲+0.046R&D / Sales ▲+0.144
Balance-sheet strength
Current ratio ▲+0.239Net debt / EBITDA ▲+0.516Working capital ▲+56432000.000Invested capital ▲+51638000.000Intangibles / Total assets n/a
Change over 5 years
Valuation
Market cap ▲+13.4%EV / Sales ▲+32.7%EV / EBITDA ▲+10.1%EV / Op. cash flow ▼-0.179Earnings yield ▼-0.010
Profitability
Return on equity ▼-0.101Return on assets ▼-0.079Return on invested capital ▼-0.115Return on capital employed ▼-0.120Operating ROA ▼-0.088Income quality ▼-0.164Tax burden +0.000
Efficiency
Days sales outstanding ▲+6.069Days payables outstanding ▲+25.490Operating cycle ▲+20.029Cash conversion cycle ▼-5.462Capex / Sales ▼-0.065R&D / Sales ▲+0.145
Balance-sheet strength
Current ratio ▼-3.402Net debt / EBITDA ▲+0.387Working capital ▼-58597000.000Invested capital ▼-72136000.000Intangibles / Total assets n/a
Employee count
Peer market caps
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2020-05-19 | Brian Jeffrey Mast | Sale (Full) | $15,001 - $50,000 |
| 2020-04-22 | Brian Jeffrey Mast | Sale (Full) | $1,001 - $15,000 |
| 2020-02-14 | Brian Jeffrey Mast | Purchase | $15,001 - $50,000 |
Recent news
- 2026-09-23 Personalis (NASDAQ:PSNL) CEO Christopher Hall Sells 7,459 Shares Personalis, Inc. (NASDAQ: PSNL - Get Free Report) CEO Christopher Hall sold 7,459 shares of the firm''s stock in a transaction that occurred on Friday, September 18th. The stock was sold at an average price of $16.22, for a total value of $120,984.98. Following the completion of the sale, the chief executive officer owned 228,527 shares
- 2026-09-21 Reviewing Personalis (NASDAQ:PSNL) and Mettler-Toledo International (NYSE:MTD) Mettler-Toledo International (NYSE: MTD - Get Free Report) and Personalis (NASDAQ: PSNL - Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, analyst recommendations and earnings. Profitability This table compares Mettler-Toledo International and Personalis'' net
- 2026-09-09 Are MKTX, HOWL, PSNL Obtaining Fair Deals for their Shareholders? Are MKTX, HOWL, PSNL Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, Sept. 9, 2026
- 2026-09-09 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Personalis, Inc. (Nasdaq – PSNL), Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), MarketAxess Holdings Inc. (Nasdaq – MKTX) BALA CYNWYD, Pa., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
- 2026-09-08 Personalis, Inc. $PSNL Shares Bought by Bank of America Corp DE Bank of America Corp DE lifted its position in shares of Personalis, Inc. (NASDAQ: PSNL) by 85.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 111,306 shares of the company''s stock after buying an additional 51,273 shares during the period. Bank
- 2026-09-02 Personalis, Inc. (NASDAQ:PSNL) Given Consensus Recommendation of “Hold” by Brokerages Personalis, Inc. (NASDAQ: PSNL - Get Free Report) has been assigned an average rating of "Hold" from the ten ratings firms that are presently covering the firm, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, four have given a hold rating and four have assigned a buy rating to
- 2026-08-04 Personalis (PSNL) Reports Q2 Loss, Tops Revenue Estimates Personalis (PSNL) came out with a quarterly loss of $0.3 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to a loss of $0.23 per share a year ago.
- 2026-08-04 Personalis Reports Second Quarter Results and Recent Highlights FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported financial and operational results for the second quarter ended June 30, 2026, and highlighted recent business accomplishments. Second Quarter and Recent Strategic and Operational Highlights Secured Medicare Coverage for IO Monitoring: Received Medicare coverage approval for NeXT Personal for immunotherapy monitoring for patients with late-stage solid tumors. Se.
- 2026-08-04 PSNL Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Personalis to Tempus AI MONSEY, N.Y., Aug. 04, 2026 (GLOBE NEWSWIRE) -- The Monsey law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Personalis, Inc. (Nasdaq: PSNL) (“Personalis”) to Tempus AI, Inc. (“Tempus”) for $16.25 per share.
- 2026-08-04 Are BOW, UTZ, PSNL Obtaining Fair Deals for their Shareholders? /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws